In an atmosphere buzzing with brain power, the latest conference in the One Nucleus Life Science Leadership series was held this week at Chesterford Research Park, near Cambridge. Delegates came together from leading life science and healthcare companies across the country to hear eminent speakers, join lively debates and make business connections. As a membership organisation for international life science and healthcare companies, One Nucleus believes these conferences are a central element of the offer that the organisation delivers to its members.
The event saw presentations that illustrated ‘state of the art’ developments in personalised medicine, stimulating debate around how the sector can capture the greatest healthcare and commercial returns from advances in the capability to target the right drug to the right patient at the right time.
Harriet Fear, Chief Executive of One Nucleus explained the thinking behind the conference’s agenda. “With our Life Science Leadership Series, one of our aims is to create communities around various vital therapeutic areas. Healthcare technologies are an obvious strength of our membership and therefore a natural focus. One Nucleus likes to work in partnership with like-minded organisations and collaborate for member and sector benefit where appropriate. We were delighted when Chesterford Research Park chose to work with us on the event. This is a location in the South Cambridge life sciences cluster where much of the great research and development in this region is taking place.”
Chesterford Research Park’s prestigious environment and range of facilities has attracted leading bioscience names including Illumina Inc, Isogenica and BioFocus. The Park’s location close to both the A11 and M11, with London just one hour away by train from nearby Audley End station, means occupiers have quick and easy access to the local road and rail infrastructure. Stansted Airport is also just 20 minutes’ drive away. To find out more visit www.chesterfordresearchpark.com
Notes for editors
Chesterford Research Park has been developed by Churchmanor Estates and is owned by Aviva Investors.